Mohammadreza Javan

Dr. Mohammadreza Javan

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
MJMohammadreza Javan
Mohammadreza Javan
NNajmaldin Saki
Najmaldin Saki
BMBahareh Moghimian‐Boroujeni
Bahareh Moghimian‐Boroujeni

9 August 2024 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
NNajmaldin Saki
Najmaldin Saki
HHHabib Haybar
Habib Haybar
MMMahmood Maniati
Mahmood Maniati
NDNader Davari
Nader Davari
MJMohammadreza Javan
Mohammadreza Javan
BMBahareh Moghimian-Boroujeni
Bahareh Moghimian-Boroujeni

29 August 2023 in Experimental Hematology
Verified
Journal Article
Closed access
MAMehrnaz Abdolalian
Mehrnaz Abdolalian
MZMahin Nikogouftar Zarif
Mahin Nikogouftar Zarif
MJMohammadreza Javan
Mohammadreza Javan

21 May 2024 in The Journal of Tehran University Heart Center
Verified
Journal Article
Open access
HRHadi Rezaeeyan
Hadi Rezaeeyan
BMBahareh Moghimian-Boroujeni
Bahareh Moghimian-Boroujeni
MAMehrnaz Abdolalian
Mehrnaz Abdolalian
MJMohammadreza Javan
Mohammadreza Javan
Background: Cardiovascular disease (CVD) is one of the principal causes of mortality in the world. Various factors have been identified in the pathogenesis of CVD. Leukemia inhibitory factor (LIF) as a secretory cytokine is one of these factors. The LIF receptor is located on endothelial cells and plays a role in the expression of specific genes in these cells. Endothelial cells are the innermost cells of blood vessels, and defects in these cells cause endothelial dysfunction and eventually CVD. Methods: The present study is based on PubMed database information (1982–2022) using the following words: “cardiovascular disease,” “endothelial cells,” “leukemia inhibitory factor,” and “angiogenesis.” Results: LIF can cause arteriosclerotic plaques by activating inflammatory mechanisms in monocytes through the induction of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression. LIF can also induce vascular endothelial growth factor expression by activating signaling pathways, eventually leading to angiogenesis. Additionally, it can activate the coagulation cascade by factor VII production promotion within endothelial cells. Conclusion Understanding the interplay between LIF and the inflammation pathways, coagulation, and angiogenesis as key factors in CVD occurrence raises the possibility of targeting this factor as a potential strategy to mitigate CVD risk.

24 August 2022 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
SBSahar Balagholi
Sahar Balagholi
RDRasul Dabbaghi
Rasul Dabbaghi
SMSaeed Mohammadi
Saeed Mohammadi
ZMZahra Abbasi Malati
Zahra Abbasi Malati
MJMohammadreza Javan
Mohammadreza Javan
PEPyman Eshghi
Pyman Eshghi

13 March 2026 in Cancers
Verified
Journal Article
Open access
PDF file
NBNima Daneshvar Baghbadorani
Nima Daneshvar Baghbadorani
MBMira Bosso
Mira Bosso
RGRowen Greene
Rowen Greene
TDTaylor Dzikowski
Taylor Dzikowski
BBBreanne Bernice Bevelander
Breanne Bernice Bevelander
MCMichael Dean Chamberlain
Michael Dean Chamberlain
Background: An emerging tool to better simulate the complexity of tumour biology in vitro is 3D culture models. Several approaches have been introduced, yet many face challenges such as technical complexity or limited ability to reproduce critical tumour traits. Modular tissue engineering is a well-known method in tissue transplantation, where it has been used to develop various healthy tissue constructs. In this study, we set out to adapt this established approach to fabricate cancer microtissues and to assess their effectiveness as a tumour model that can capture essential features of cancer biology and drug-treatment response. Methods: Two triple-negative breast cancer (TNBC) cell lines, HCC1806 and MDA-MB-231, were cultured in microtissues and assessed for viability, cell death, generation of hypoxia and response to chemotherapy. To benchmark our model, we utilized flow cytometry to analyze the CD44+/CD24− cancer stem cell (CSC) phenotype across microtissues, 2D monolayers, and established 3D models, including spheroids, collagen domes, and laminin-rich domes. Results: The cells showed sustained cell viability with minimal cell death, along with natural development of tumour properties, such as hypoxia. Crucially, flow cytometry revealed a cell-line-dependent regulation of the CD44+/CD24− phenotype, underscoring the complex influence of the 3D microenvironment on stem cell regulation. Furthermore, by screening the model with standard anti-breast cancer chemotherapeutics, we observed drug resistance at concentrations comparable to those used in the clinic. Conclusions: Our model offers the unique ability to spontaneously reproduce fundamental features of tumours in vitro, capturing the cellular heterogeneity and reprogramming that drive clinical drug resistance.